William Weldon is Chairman and Chief Executive Officer of Johnson & Johnson and is the sixth Chairman in Johnson & Johnson's over one-hundred year history.
Weldon joined J&J as a sales representative for the McNeil Pharameutical division in 1971 and eventually became the head of J&J's Ethicon Endo-Surgery business in 1992. He became the head of J&J's pharmaceutical operations in 1998 and then became J&J's CEO in 2002. As CEO, Weldon engineered some of the largest acquisitions in J&J's history including the purchase of ALZA and Pfizer's consumer-health product line.
William Weldon received a BA in Biology from Quinnipiac University.
We are now working in personalized medicine. We've got an oncology group that is made up of diagnostics people and pharmaceutical people, and they are looking at biomarkers and genetic markers of patients who were given drugs. So, we're going to be able to determine who is a responder and who is n...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
